VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 180 filers reported holding VANDA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 3.16 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $0 | – | 40 | 0.0% | 0.00% | – |
| Q3 2022 | $0 | – | 40 | -43.7% | 0.00% | – |
| Q2 2022 | $0 | -100.0% | 71 | -42.3% | 0.00% | – |
| Q1 2022 | $1,000 | -90.9% | 123 | -82.5% | 0.00% | – |
| Q4 2021 | $11,000 | +266.7% | 704 | +252.0% | 0.00% | – |
| Q3 2021 | $3,000 | -25.0% | 200 | 0.0% | 0.00% | – |
| Q2 2021 | $4,000 | -33.3% | 200 | -60.0% | 0.00% | – |
| Q4 2020 | $6,000 | +50.0% | 500 | 0.0% | 0.00% | – |
| Q3 2020 | $4,000 | -33.3% | 500 | -10.6% | 0.00% | – |
| Q2 2020 | $6,000 | -14.3% | 559 | -16.3% | 0.00% | – |
| Q1 2020 | $7,000 | -36.4% | 668 | 0.0% | 0.00% | – |
| Q4 2019 | $11,000 | +57.1% | 668 | +24.9% | 0.00% | – |
| Q3 2019 | $7,000 | -12.5% | 535 | -6.1% | 0.00% | – |
| Q2 2019 | $8,000 | -52.9% | 570 | -39.4% | 0.00% | – |
| Q1 2019 | $17,000 | – | 940 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 2,491,200 | $27,154,000 | 2.37% |
| Profit Investment Management, LLC | 281,890 | $3,071,000 | 2.26% |
| Sio Capital Management, LLC | 488,965 | $5,330,000 | 2.00% |
| Zebra Capital Management LLC | 14,766 | $161,000 | 0.47% |
| Prairiewood Capital, LLC | 50,165 | $547,000 | 0.43% |
| TANG CAPITAL MANAGEMENT LLC | 256,696 | $2,798,000 | 0.42% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 156,000 | $1,700,000 | 0.29% |
| GLOBEFLEX CAPITAL L P | 100,843 | $1,099,000 | 0.27% |
| Epoch Investment Partners, Inc. | 2,757,646 | $30,059,000 | 0.18% |
| EMC Capital Management | 16,185 | $176,000 | 0.15% |